Sort
261,768 grants matching “gene therapy”
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,623,635Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2020 · AG
Molecular Genetics of Coagulation Disorders
$1,623,521David Ginsburg · University Of Michigan At Ann Arbor · P01 · FY2012 · HL
Information Signaling Pathways in the Vasculature
$1,623,446Dudley K. Strickland · University Of Maryland Baltimore · P01 · FY2010 · HL
Information Signaling Pathways in the Vasculature
$1,623,446Dudley K. Strickland · University Of Maryland Baltimore · P01 · FY2008 · HL
Information Signaling Pathways in the Vasculature
$1,623,446Dudley K. Strickland · University Of Maryland Baltimore · P01 · FY2009 · HL
Information Signaling Pathways in the Vasculature
$1,623,446Dudley K. Strickland · University Of Maryland Baltimore · P01 · FY2011 · HL
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,623,430Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Sex Differences in Major Depression: Impact of Prenatal Stress-Immune and Autonomic Dysregulation
$1,623,347Jill M Goldstein · Massachusetts General Hospital · U54 · FY2021 · MH
NIAMS: CORT
$1,623,290Robert A Lafyatis · Boston University Medical Campus · P50 · FY2012 · AR
1/2 Genetics at an extreme: an efficient genomic study of individuals with clinically severe major depression receiving ECT
$1,623,286Peter P Zandi · Johns Hopkins University · R01 · FY2021 · MH
Repurposing an EU Therapeutic for Hemoglobinopathies
$1,623,279Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
KnowEng, a Scalable Knowledge Engine for Large-Scale Genomic Data-OVERALL
$1,623,265Jiawei Han · University Of Illinois At Urbana-Champaign · U54 · FY2014 · GM
MITOCHONDRIAL ENCEPHALOMYOPATHIES: APPROACHES TO TREATMENT
$1,623,247Salvatore Dimauro · Columbia University Health Sciences · P01 · FY2014 · HD
1/2 Genetics at an extreme: an efficient genomic study of individuals with clinically severe major depression receiving ECT
$1,623,239Peter P Zandi · Johns Hopkins University · R01 · FY2023 · MH
Biomarkers to Predict Patient Outcomes and Guide Therapies
$1,623,176Ann Cashion · National Institute Of Nursing Research · ZIA · FY2015 · NR
Inherited Ocular Diseases
$1,623,105James F. Hejtmancik · National Eye Institute · ZIA · FY2009 · EY
NIAMS: CORT
$1,622,952Robert W Simms · Boston University Medical Campus · P50 · FY2015 · AR
NIAMS: CORT
$1,622,905Robert A Lafyatis · Boston University Medical Campus · P50 · FY2014 · AR
Mitochondrial Oxidative Metabolism is a critical determinant of Muscle Satellite Cell fate & function
$1,622,775Sara Marie Nowinski · Van Andel Research Institute · R01 · FY2025 · AR
Program on Genetic and Dietary Predictors of Drug Response in Rural and AI/AN Populations
$1,622,683Kenneth E. Thummel · University Of Washington · P01 · FY2018 · GM
Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genome
$1,622,560Konstantinos N Lazaridis · Mayo Clinic Rochester · RC2 · FY2018 · DK
Oral Carcinogenesis
$1,622,112J Gutkind · National Institute Of Dental & Craniofacial Research · ZIA · FY2009 · DE
Molecular Atlas of Lung Development - Data Coordinating Center
$1,622,063Scott M Palmer · Duke University · U01 · FY2015 · HL
Genomics of Kidney Transplantation
$1,621,888Arthur J Matas · University Of Minnesota · U19 · FY2010 · AI
Functional Genomics of Human Brain Development
$1,621,706Nenad Sestan · Yale University · P50 · FY2016 · MH